European Archives - Page 187 of 1392 - European Medical Journal

Key Driver of Food-Allergy-Induced Anaphylaxis in Mice Identified

Two new studies have identified cysteinyl leukotrienes as key drivers of food-allergy-induced anaphylaxis in mice.

Breaking Free from Glucocorticoids in PMR

In this symposium, Anisha Bharadwaj Dua explored the prevalence and impact of comorbidities in patients with…

How to Screen for Hepatitis C Virus Effectively in Emergency Departments

New findings suggest that non-targeted screening for hepatitis C virus may be more effective than targeted screening for identifying new HCV infections in the emergency department.

Breakthrough Imaging Delivers Deepest Ever Images Of Living Brain Cells

New imaging tech offers unprecedented, non-invasive single-cell views deep within living brain tissue.

How to Tackle Exercise Barriers in Inflammatory Myopathies?

People with idiopathic inflammatory myopathies (IIM) face unique physical and emotional challenges when it comes to exercise.

5 minutes with Dr Henar Hevia, J&J Innovative Medicine

Henar Hevia, Senior Director, EMEA Therapeutic Area Lead, Oncology, reveals what it’s like to work in oncology today, especially at J&J.

Breaking Barriers in Cervical Cancer Screening for LGBTQ+ AFAB Individuals

New research highlights how outdated cervical cancer screening guidelines in the U.S. fail to meet the needs of sexual and gender minoritized (SGM) people assigned female at birth.

AstraZeneca and Viseven win 2025 HBA ACE Awards

AstraZeneca and Viseven win the 2025 HBA ACE Awards for innovative workforce and community programmes shaping the future of healthcare.

Labelling Shown to Affect Views on Early Blood Conditions

A new study finds that the way early blood conditions like clonal cytopenia of undetermined significance (CCUS) are labelled significantly affects how people perceive the disease and what treatments they prefer.

Study Uncovers Biomarkers That Could Guide Chronic Kidney Disease Care

A large UK study has shown that novel biomarkers reflecting kidney damage, fibrosis, inflammation, and cardiovascular disease can predict kidney failure and all-cause mortality in chronic kidney disease (CKD) with accuracy similar to established clinical risk factors.